Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 14.09.2026 1 AJNR Am J Neuroradiol 2 Brain 2 J Neuroimmunol 5 J Neurol 1 J Neurol Neurosurg Psychiatry 1 J Neurol Sci 1 Mult Scler 1 Nat Rev Neurol 1 Proc Natl Acad Sci U S A 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. CHIANG FL, Krijnen EA, Hobbs DA, Lee H, et al
   Microstructural Characterization of Functional Network-Based Neurodegeneration in Multiple Sclerosis Using High-Gradient Diffusion MRI.
   AJNR Am J Neuroradiol. 2026 Sep 9:ajnr.A9632. doi: 10.3174/ajnr.A9632.
   PubMed         Abstract available
   
   

   
   Brain

2. FAROOQ R, Cutler B, Pisa M, Balaram Kuttikkatte S, et al
   Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis.
   Brain. 2026 Sep 9:awag303. doi: 10.1093.
   PubMed         Abstract available
   
   
3. BROWN JWL
   Untangling prognosis in multiple sclerosis.
   Brain. 2026;149:2909-2911.
   PubMed        
   
   

   
   J Neuroimmunol

4. ERICHSEN PA, Heerfordt IM, Framke E, Magyari M, et al
   Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.
   J Neuroimmunol. 2026;421:579097.
   PubMed         Abstract available
   
   
5. WILBUR C, Zhu F, Zhao Y, Tremlett H, et al
   Disease-modifying therapy uptake in a pediatric-onset multiple sclerosis population, British Columbia, Canada.
   J Neuroimmunol. 2026;421:579083.
   PubMed         Abstract available
   
   

   
   J Neurol

6. MATTIESING RM, Gentile G, Battaglini M, De Stefano N, et al
   The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis.
   J Neurol. 2026;273:584.
   PubMed         Abstract available
   
   
7. ESPOSITO A, Corsaro L, Cave ID, Capasso F, et al
   Ofatumumab in multiple sclerosis: 2-year immune profiling and clinical correlates.
   J Neurol. 2026;273:579.
   PubMed         Abstract available
   
   
8. MARINO V, Moiola L, Zanetta C, Rubin M, et al
   Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison.
   J Neurol. 2026;273:577.
   PubMed        
   
   
9. GUO J, Wu J, Olsson T, Alfredsson L, et al
   Genetic modification of obesity-associated disability progression in multiple sclerosis.
   J Neurol. 2026;273:578.
   PubMed         Abstract available
   
   
10. MULLER T, Giles L, Hauquiert B, Gonze A, et al
    Severe invasive pneumococcal pneumonia following influenza A in a patient with multiple sclerosis treated with dimethyl fumarate: the importance of vaccination assessment and hematologic monitoring.
    J Neurol. 2026;273:571.
    PubMed        
    
    

    
    J Neurol Neurosurg Psychiatry

11. BARBUTI E, Borrelli S, Guisset F, London F, et al
    MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.
    J Neurol Neurosurg Psychiatry. 2026 Sep 10:jnnp-2026-339497.
    PubMed         Abstract available
    
    

    
    J Neurol Sci

12. REGEV K, Lotan I, Zmira O, Golan D, et al
    Clinical decision-making in older adults with multiple sclerosis: A National Delphi survey of Israeli MS specialists.
    J Neurol Sci. 2026;490:126171.
    PubMed         Abstract available
    
    

    
    Mult Scler

13. GIOVANNETTI AM, Pakenham KI, Copetti M, Brichetto G, et al
    A group resilience training program for people with multiple sclerosis: A cluster-randomized controlled trial (multi-READY for MS).
    Mult Scler. 2026 Sep 7:13524585261464886. doi: 10.1177/13524585261464886.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

14. CALABRESE M, Magliozzi R, Tamanti A, Ziccardi S, et al
    Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.
    Nat Rev Neurol. 2026 Sep 7. doi: 10.1038/s41582-026-01263.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

15. NANOU A, Apostolou-Karampelis K, Triantafyllidou V, Sakkou M, et al
    Fibronectin inhibition restores myelination in endothelial TNFR2-dependent nonremitting experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2026;123:e2616799123.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

16. MAINGUY M, Massot C, Gallien P, Reynaud V, et al
    Access to hospital-based rehabilitation for people with multiple sclerosis in France: A nationwide study (2017-2023).
    Rev Neurol (Paris). 2026 Sep 7:S0035-3787(26)00584.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum